Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Levothyroxine sodium 75micrograms/5ml oral liquid
0602010V0AACVCV
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | No data available |
|
Levothyroxine sodium 80micrograms/5ml oral liquid
0602010V0AAEVEV
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | No data available |
|
Levothyroxine sodium 87.5micrograms/5ml oral liquid
0602010V0AAFXFX
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | No data available |
|
Levothyroxine sodium 9.5microg / Liothyronine 2.25microg tab
0602010Z0AAAEAE
|
Levothyroxine sodium/liothyronine | Levothyroxine sodium and liothyronine | Endocrine System | No data available |
|
Levothyroxine sodium 90micrograms/5ml oral liquid
0602010V0AAEIEI
|
Levothyroxine sodium | Levothyroxine sodium | Endocrine System | No data available |
|
Linzagolix 200mg tablets
0607020Y0AAACAC
|
Linzagolix | Linzagolix | Endocrine System | No data available |
|
Liothyronine 100micrograms/5ml oral liquid
0602010M0AAAMAM
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 10micrograms/5ml oral suspension
0602010M0AAATAT
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 10micrograms/ml oral solution
0602010M0AABBBB
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 10micrograms/ml oral solution sugar free
0602010M0AABCBC
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 20microgram inj vials
0602010M0AAAVAV
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 20microgram solution for injection ampoules
0602010M0AAABAB
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 20micrograms/5ml oral suspension
0602010M0AAAXAX
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 25micrograms/5ml oral suspension
0602010M0AAAYAY
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 37.5micrograms/5ml oral liquid
0602010M0AAAKAK
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 50microgram tablets
0602010M0AAASAS
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 50micrograms/5ml oral liquid
0602010M0AAALAL
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Liothyronine 5micrograms/5ml oral liquid
0602010M0AAANAN
|
Liothyronine sodium | Liothyronine sodium | Endocrine System | No data available |
|
Lodotra 1mg modified-release tablets
0603020X0BDAAAE
|
Lodotra | Prednisone | Endocrine System | No data available |
|
Lodotra 2mg modified-release tablets
0603020X0BDABAF
|
Lodotra | Prednisone | Endocrine System | No data available |
|
Lodotra 5mg modified-release tablets
0603020X0BDACAG
|
Lodotra | Prednisone | Endocrine System | No data available |
|
Loron 400mg capsules
0606020T0BBAAAA
|
Loron | Sodium clodronate | Endocrine System | No data available |
|
Lubion 25mg/1.112ml inj pre-filled syringes
0604012S0BPACCF
|
Lubion | Progesterone | Endocrine System | No data available |
|
Lubion 25mg/1.119ml solution for injection vials
0604012S0BPAACB
|
Lubion | Progesterone | Endocrine System | No data available |
|
Lusama 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BGAAAC
|
Lusama | Teriparatide | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.